Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v6-EN | Version v1-EN | |
---|---|---|
Language | English | English |
Date Updated | 2018-03-06 | 2018-02-01 |
Drug Identification Number | 02278057 | 02278057 |
Brand name | VOLUVEN | VOLUVEN |
Common or Proper name | Voluven | Voluven |
Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
Ingredients | HYDROXYETHYL STARCH 130/0.4 | HYDROXYETHYL STARCH 130/0.4 |
Strength(s) | 6% | 6% |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | INTRAVENOUS | INTRAVENOUS |
Packaging size | 250 mL Bag | 250 mL Bag |
ATC code | B05AA | B05AA |
ATC description | BLOOD AND RELATED PRODUCTS | BLOOD AND RELATED PRODUCTS |
Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
Anticipated start date | 2018-02-01 | 2018-02-01 |
Actual start date | ||
Estimated end date | 2018-03-01 | 2018-03-01 |
Actual end date | 2018-03-05 | |
Shortage status | Resolved | Anticipated shortage |
Tier 3 Status | No | No |
Company comments | During the supply shortage, Voluven 500 mL Bag and Volulyte 250 mL Bag will be available for substitution. | During the supply shortage, Voluven 500 mL Bag and Volulyte 250 mL Bag will be available for substitution. |
Health Canada comments |